Comparison of Efficacy of Pembrolizumab Between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas

Cancer Research and Treatment - South Korea
doi 10.4143/crt.2018.191
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Cancer Association


Related search